研究表明：利用大劑量的諾和諾德公司的抗凝血藥來(lái)治療非血友病的患者，比如出血中風(fēng)，外傷，手術(shù)，器官移植等，可能會(huì )提高心臟病發(fā)作的風(fēng)險。

The drug, NovoSeven, is a genetically engineered version of factor VII, a key protein missing in some people with the bleeding disease hemophilia.

Some doctors prescribe the drug in "off-label" use to stop unwanted bleeding associated with stroke, trauma, surgery, transplantation and other medical conditions. Doctors may prescribe any approved drug for any reason they want to.